相关实验视频
Updated: May 22, 2025

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.6K
发现和设计组织等离子体激活剂的策略:对生物工程目标的洞察力
Amirhossein Akbarpour Arsanjani1, Davood Rabiei Faradonbeh1, Ziba Veisi Malekshahi1
1Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Drug development research
|March 13, 2025
概括
发现和工程组织等离子体激活剂 (tPAs) 的新策略旨在改进对血栓性疾病的血栓溶解疗法,解决诸如出血风险和短半衰期之类的局限性.
科学领域:
- 生物化学和分子生物学
- 药理学和治疗学 药理学和治疗学
- 心血管研究研究心血管研究
背景情况:
- 组织等离子素激活剂 (tPAs) 对于纤维素分解和治疗心脏病发作和中风等血栓性疾病至关重要.
- 目前的tPA面临挑战,包括出血并发症,纤维素特异性差,快速清除,需要改进的治疗剂.
研究的目的:
- 审查目前用于从各种自然来源发现新型tPA的战略.
- 探索酶工程方法来增强tPA的功能特性.
- 讨论独立于tPAs的替代性血栓解毒策略.
主要方法:
- 对自然tPA来源 (人类,细菌,毒液,蝙蝠唾液) 的文献综述.
- 分析酶工程技术以改善tPA半衰期,纤维素特异性,抑制剂耐药性和凝块透.
- 探索非等离子素激活剂和血小板向策略.
主要成果:
- 为了发现tPA,确定各种自然来源.
- 展示成功的酶工程,以提高tPA的疗效和安全性.
- 对有前途的替代性血栓溶解方法的概述.
结论:
- 推进血栓溶解疗法需要对tPAs进行创新的发现和设计.
- 工程tPA和探索替代剂是克服当前治疗局限性的关键.
- 未来的研究应该专注于开发更安全,更有效的凝块破坏治疗方法.
相关概念视频
Clot Retraction and Fibrinolysis
3.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
446
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
446
Anticoagulant Drugs: Low-Molecular-Weight Heparins
586
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
586

